Drug Type Liposomal Drug |
Synonyms |
Action inhibitors |
Mechanism CAVIN1 inhibitors(caveolae associated protein 1 inhibitors), CAVIN2 inhibitors(caveolae associated protein 2 inhibitors), CAVIN3 inhibitors(caveolae associated protein 3 inhibitors) + [2] |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Glioblastoma | Preclinical | United States | 25 Nov 2024 |